{
    "2021-05-09": [
        [
            {
                "time": "2021-05-09",
                "original_text": "复星医药拟成立合资公司，在中国生产mRNA 新冠疫苗",
                "features": {
                    "keywords": [
                        "复星医药",
                        "mRNA",
                        "新冠疫苗",
                        "合资公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "公告精选：复星医药子公司拟与BioNTech设合资公司；龙蟒佰利上调钛白粉售价",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BioNTech",
                        "合资",
                        "钛白粉",
                        "龙蟒佰利"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "复星医药(02196)：复星医药产业与BioNTech拟就新冠疫苗产品的本地化生产及商业化设立合资公司",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BioNTech",
                        "新冠疫苗",
                        "本地化生产",
                        "商业化"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "复星医药(02196.HK)子公司拟与BioNTech设立合资公司实现新冠疫苗产品本地化生产及商业化",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BioNTech",
                        "新冠疫苗",
                        "本地化生产",
                        "商业化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "新冠疫苗专利将开放?产能受限难救急，国内疫苗企业扩产稳为上",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "专利开放",
                        "产能受限",
                        "扩产"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-05-09",
                "original_text": "上海区域股市周报：澜起科技市值缩水最多 复星医药进入上海股市值前10强 连续下跌",
                "features": {
                    "keywords": [
                        "复星医药",
                        "上海股市",
                        "市值",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}